Stockscreener 앱 받기
7.27
9.98%
0.66
시간 외 거래:
7.35
0.08
+1.10%
전일 마감가:
$6.61
열려 있는:
$6.64
하루 거래량:
763.99K
Relative Volume:
0.72
시가총액:
$339.53M
수익:
$20.72M
순이익/손실:
$-100.84M
주가수익비율:
-2.7331
EPS:
-2.66
순현금흐름:
$-78.56M
1주 성능:
+18.02%
1개월 성능:
+20.17%
6개월 성능:
+74.76%
1년 성능:
-53.13%
1일 변동 폭
$6.5324
$7.31
1주일 범위
$5.97
$7.31
52주 변동 폭
$2.235
$17.41
4D몰큘러 테라퓨틱스 Stock (FDMT) Company Profile
명칭
4 D Molecular Therapeutics Inc
전화
(510) 505-2680
주소
5858 HORTON STREET #455, EMERYVILLE
FDMT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FDMT
4 D Molecular Therapeutics Inc
|
7.27 | 308.70M | 20.72M | -100.84M | -78.56M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
4D몰큘러 테라퓨틱스 Stock (FDMT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-13 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-11-21 | 개시 | Morgan Stanley | Underweight |
| 2024-09-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-04-15 | 개시 | Barclays | Overweight |
| 2024-02-07 | 재개 | Goldman | Buy |
| 2023-10-26 | 개시 | RBC Capital Mkts | Outperform |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-18 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | 개시 | Chardan Capital Markets | Buy |
| 2023-01-30 | 개시 | BMO Capital Markets | Outperform |
| 2022-11-18 | 개시 | H.C. Wainwright | Buy |
| 2022-11-15 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-08-12 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-06-22 | 개시 | Jefferies | Buy |
| 2022-01-04 | 개시 | SVB Leerink | Outperform |
| 2021-01-05 | 개시 | BofA Securities | Buy |
| 2021-01-05 | 개시 | Evercore ISI | Outperform |
| 2021-01-05 | 개시 | Goldman | Neutral |
모두보기
4D몰큘러 테라퓨틱스 주식(FDMT)의 최신 뉴스
Real time scanner hits for 4D Molecular Therapeutics Inc. explainedMarket Trend Review & Risk Adjusted Buy and Sell Alerts - Newser
Should you wait for a breakout in 4D Molecular Therapeutics Inc.Index Update & Long-Term Growth Plans - Newser
Can 4D Molecular Therapeutics Inc. navigate macro headwindsJuly 2025 Summary & Fast Gaining Stock Reports - خودرو بانک
Can 4D Molecular Therapeutics Inc. lead its sector in growthMarket Risk Report & AI Forecasted Entry and Exit Points - خودرو بانک
Should you avoid 4D Molecular Therapeutics Inc. stock right nowQuarterly Trade Summary & Consistent Profit Trade Alerts - خودرو بانک
Smart tools for monitoring 4D Molecular Therapeutics Inc.’s price actionQuarterly Portfolio Review & Reliable Entry Point Alerts - Newser
Chart based analysis of 4D Molecular Therapeutics Inc. trendsJuly 2025 Selloffs & Short-Term High Return Strategies - Newser
Candlestick signals on 4D Molecular Therapeutics Inc. stock todayTrade Ideas & AI Optimized Trading Strategy Guides - Newser
How sensitive is 4D Molecular Therapeutics Inc. to inflationTrade Risk Report & Expert Approved Momentum Ideas - خودرو بانک
Is 4D Molecular Therapeutics Inc. a candidate for recovery playGold Moves & Precise Entry and Exit Recommendations - Newser
What indicators show strength in 4D Molecular Therapeutics Inc.July 2025 Trends & Weekly Market Pulse Alerts - Newser
Ranking 4D Molecular Therapeutics Inc. among high performing stocks via toolsTrend Reversal & Free Safe Capital Growth Stock Tips - Newser
Russell Investments Group Ltd. Takes $63,000 Position in 4D Molecular Therapeutics, Inc. $FDMT - Defense World
Can 4D Molecular Therapeutics Inc. reach all time highs this yearMarket Activity Recap & Safe Investment Capital Preservation Plans - خودرو بانک
Jim Cramer on 4D Molecular Therapeutics: “This is a Pure Spec” - Insider Monkey
Nuveen LLC Invests $486,000 in 4D Molecular Therapeutics, Inc. $FDMT - Defense World
Is this a good reentry point in 4D Molecular Therapeutics Inc.July 2025 Closing Moves & Scalable Portfolio Growth Ideas - Newser
Volume spikes in 4D Molecular Therapeutics Inc. stock – what they mean - Newser
4D Molecular Therapeutics Inc. recovery potential after sell offCPI Data & Fast Moving Trade Plans - Newser
4D Molecular Therapeutics Soars 11.9% on Positive Outlook - AInvest
Can 4D Molecular Therapeutics Inc. sustain its profitability2025 Year in Review & Fast Gaining Stock Reports - خودرو بانک
Jim Cramer Advises Prudence on AppLovin, Calls 4D Molecular Therapeutics a "Pure Spec" - AInvest
Multi asset correlation models including 4D Molecular Therapeutics Inc.July 2025 Update & Daily Price Action Insights - Newser
4D Molecular Therapeutics Inc. stock trendline breakdown2025 Bull vs Bear & Reliable Price Breakout Signals - Newser
How to track smart money flows in 4D Molecular Therapeutics Inc.July 2025 Pullbacks & Weekly High Potential Stock Alerts - Newser
What momentum shifts mean for 4D Molecular Therapeutics Inc.Long Setup & Weekly High Return Stock Opportunities - Newser
Detecting support and resistance levels for 4D Molecular Therapeutics Inc.Layoff News & Weekly Top Stock Performers List - Newser
Using Python tools to backtest 4D Molecular Therapeutics Inc. strategies2025 Historical Comparison & Precise Swing Trade Entry Alerts - Newser
4DMT Announces Leadership Expansion with Proven Late-Stage - GlobeNewswire
Former IZERVAY Developer Takes CMO Role: 4DMT Accelerates Phase 3 Wet AMD Gene Therapy Timeline - Stock Titan
Top chart patterns to watch in 4D Molecular Therapeutics Inc.Weekly Earnings Recap & Safe Entry Point Identification - Newser
Exit strategy if you’re trapped in 4D Molecular Therapeutics Inc.July 2025 Technicals & Smart Allocation Stock Tips - Newser
Real time social sentiment graph for 4D Molecular Therapeutics Inc.Trade Ideas & Safe Capital Preservation Plans - Newser
What is 4D Molecular Therapeutics Inc.’s book value per share2025 Market Overview & Weekly High Return Stock Forecasts - خودرو بانک
How do insiders feel about 4D Molecular Therapeutics Inc.July 2025 Opening Moves & Weekly High Return Opportunities - خودرو بانک
Can trapped investors hope for a rebound in 4D Molecular Therapeutics Inc.Insider Buying & Step-by-Step Swing Trade Plans - Newser
4D몰큘러 테라퓨틱스 (FDMT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):